FIP1L1

Pre-mRNA 3'-end-processing factor FIP1 · Q6UN15 · FIP1L1 on Sugi Atlas →

0 patent compounds predicted against FIP1L1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to FIP1L1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB PHASE2COMPLETED
Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer PHASE2ACTIVE_NOT_RECRUITING
SGI-110 and Donor Lymphocyte Infusions (DLI) After Allogeneic Stem Cell Transplantation PHASE2UNKNOWN
68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Oral Paclitaxel for Patients with Advanced Solid Tumors PHASE1RECRUITING
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia nanRECRUITING
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma nanNO_LONGER_AVAILABLE
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Study of Specimens From Young Patients With Neuroblastoma nanCOMPLETED
Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study nanCOMPLETED
INFLAmmasomes NLRP3 in Platelets and Leukocytes During SEPSIS in Intensive Care Unit nanCOMPLETED
Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk nanWITHDRAWN
The Role of Fibroblast Activation in Uterine Fibroid nanCOMPLETED
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear nanUNKNOWN
Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer nanUNKNOWN
Gluten-related Disorders in Familial Mediterranean Fever Patients nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics] nanCOMPLETED
Biomarker in Tissue Samples From Patients With Ewing Sarcoma nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a FIP1L1 binder may also engage these)

ProteinNameSimilarity
Q9D824 1.000 Q9D824 →
Q5RAA7 1.000 Q5RAA7 →
Q5U317 1.000 Q5U317 →
P97868 1.000 P97868 →
Q5XJD3 0.999 Q5XJD3 →
Q09801 0.999 Q09801 →
PPHLN1 Periphilin-1 0.996 landscape →
Q66J90 0.995 Q66J90 →
Q872I5 0.994 Q872I5 →
F1QIC4 0.994 F1QIC4 →
Q4I5R3 0.993 Q4I5R3 →
P0CO16 0.993 P0CO16 →
Q9P7S9 0.993 Q9P7S9 →
Q6H7U2 0.993 Q6H7U2 →
P0CO17 0.993 P0CO17 →
Q96IZ0 0.992 Q96IZ0 →
Q08D57 0.992 Q08D57 →
Q9XTT4 0.992 Q9XTT4 →
Q18221 0.992 Q18221 →
A4R227 0.992 A4R227 →
Q92259 0.992 Q92259 →
Q10033 0.992 Q10033 →
Q9LFE0 0.992 Q9LFE0 →
BPTF Nucleosome-remodeling factor subunit BPTF 0.992 landscape →
Q6PEI3 0.991 Q6PEI3 →
PRRC2C Protein PRRC2C 0.991 landscape →
Q95XU6 0.991 Q95XU6 →
Q91VJ5 0.991 Q91VJ5 →
A5DLJ8 0.991 A5DLJ8 →
A1YFA7 0.991 A1YFA7 →